Logo image of WAY

WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

NASDAQ:WAY - Nasdaq - US9467841055 - Common Stock - Currency: USD

42.21  +1.21 (+2.95%)

After market: 42.22 +0.01 (+0.02%)

Fundamental Rating

5

Taking everything into account, WAY scores 5 out of 10 in our fundamental rating. WAY was compared to 39 industry peers in the Health Care Technology industry. WAY has only an average score on both its financial health and profitability. WAY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year WAY has reported negative net income.
WAY had a positive operating cash flow in the past year.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With an excellent Return On Assets value of -0.42%, WAY belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
With an excellent Return On Equity value of -0.62%, WAY belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
WAY has a better Return On Invested Capital (2.21%) than 81.08% of its industry peers.
WAY had an Average Return On Invested Capital over the past 3 years of 2.09%. This is below the industry average of 6.44%.
The last Return On Invested Capital (2.21%) for WAY is above the 3 year average (2.09%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.42%
ROE -0.62%
ROIC 2.21%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 -1 2 -2

1.3 Margins

With an excellent Operating Margin value of 13.11%, WAY belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
In the last couple of years the Operating Margin of WAY has grown nicely.
The Gross Margin of WAY (66.54%) is better than 64.86% of its industry peers.
WAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.11%
PM (TTM) N/A
GM 66.54%
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
WAY has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WAY has been reduced compared to a year ago.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.11 indicates that WAY is not in any danger for bankruptcy at the moment.
The Altman-Z score of WAY (3.11) is better than 70.27% of its industry peers.
WAY has a debt to FCF ratio of 8.73. This is a slightly negative value and a sign of low solvency as WAY would need 8.73 years to pay back of all of its debts.
WAY has a Debt to FCF ratio (8.73) which is in line with its industry peers.
WAY has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
WAY has a Debt to Equity ratio (0.40) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.73
Altman-Z 3.11
ROIC/WACC0.22
WACC9.92%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

WAY has a Current Ratio of 2.55. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
WAY has a Current ratio of 2.55. This is in the better half of the industry: WAY outperforms 67.57% of its industry peers.
WAY has a Quick Ratio of 2.55. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of WAY (2.55) is better than 67.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.58% over the past year.
Looking at the last year, WAY shows a quite strong growth in Revenue. The Revenue has grown by 19.28% in the last year.
Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 17.71% on average per year.
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%227.83%
Revenue 1Y (TTM)19.28%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%18.1%

3.2 Future

Based on estimates for the next years, WAY will show a very strong growth in Earnings Per Share. The EPS will grow by 52.79% on average per year.
WAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.66% yearly.
EPS Next Y232.48%
EPS Next 2Y98.3%
EPS Next 3Y52.79%
EPS Next 5YN/A
Revenue Next Year7.55%
Revenue Next 2Y8.66%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

WAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 40.03, which means the current valuation is very expensive for WAY.
WAY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WAY is cheaper than 78.38% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. WAY is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 40.03
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WAY is valued a bit cheaper than 75.68% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 64.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 50.97
EV/EBITDA 26.16
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WAY's earnings are expected to grow with 52.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.3%
EPS Next 3Y52.79%

More info and screens

0

5. Dividend

5.1 Amount

WAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WAYSTAR HOLDING CORP

NASDAQ:WAY (2/21/2025, 8:00:02 PM)

After market: 42.22 +0.01 (+0.02%)

42.21

+1.21 (+2.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)N/A N/A
Inst Owners52.38%
Inst Owner Change2.36%
Ins Owners1.15%
Ins Owner Change0%
Market Cap7.26B
Analysts84.29
Price Target41.62 (-1.4%)
Short Float %5.65%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.95%
Min EPS beat(2)29.95%
Max EPS beat(2)103.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.18%
Min Revenue beat(2)4.13%
Max Revenue beat(2)6.23%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.21%
PT rev (3m)25.93%
EPS NQ rev (1m)-3.13%
EPS NQ rev (3m)0.64%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)16.78%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.73%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.03
P/S 7.7
P/FCF 50.97
P/OCF 42.79
P/B 2.36
P/tB N/A
EV/EBITDA 26.16
EPS(TTM)-0.16
EYN/A
EPS(NY)1.05
Fwd EY2.5%
FCF(TTM)0.83
FCFY1.96%
OCF(TTM)0.99
OCFY2.34%
SpS5.48
BVpS17.9
TBVpS-5.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.42%
ROE -0.62%
ROCE 2.79%
ROIC 2.21%
ROICexc 2.3%
ROICexgc 51.39%
OM 13.11%
PM (TTM) N/A
GM 66.54%
FCFM 15.1%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexcg growth 3Y7.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score6
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.73
Debt/EBITDA 3.97
Cap/Depr 14.61%
Cap/Sales 2.89%
Interest Coverage 250
Cash Conversion 54.7%
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 3.11
F-Score6
WACC9.92%
ROIC/WACC0.22
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%227.83%
EPS Next Y232.48%
EPS Next 2Y98.3%
EPS Next 3Y52.79%
EPS Next 5YN/A
Revenue 1Y (TTM)19.28%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%18.1%
Revenue Next Year7.55%
Revenue Next 2Y8.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.92%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year121.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A